| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/19/2009 | CN101511815A New pyridine analogues |
| 08/19/2009 | CN101511813A Heterocyclic FXR binding compounds |
| 08/19/2009 | CN101511812A Pyrazole derivatives as cytochrome P450 inhibitors |
| 08/19/2009 | CN101511809A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/19/2009 | CN101511808A Diaryl ether derivatives and uses thereof |
| 08/19/2009 | CN101511807A Substituted benzamide modulators of the histamine H3 receptor |
| 08/19/2009 | CN101511805A Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands |
| 08/19/2009 | CN101511804A Cyclic sulfones useful as mitochondrial sodium-calcium exchangers |
| 08/19/2009 | CN101511802A Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 08/19/2009 | CN101511801A Triazine derivative compound and composition for treating cancer containing them |
| 08/19/2009 | CN101511800A Triazolyl phenyl benzenesulfonamides |
| 08/19/2009 | CN101511799A Cyclic amine compound |
| 08/19/2009 | CN101511798A [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 08/19/2009 | CN101511797A Benzimidazole modulators of VR1 |
| 08/19/2009 | CN101511796A Imidazole derivative |
| 08/19/2009 | CN101511795A 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 08/19/2009 | CN101511794A Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 08/19/2009 | CN101511793A Antitumor agent for undifferentiated gastric cancer |
| 08/19/2009 | CN101511792A New pyridine analogues |
| 08/19/2009 | CN101511791A Piperazinyl derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 08/19/2009 | CN101511790A Substituted aminomethyl benzamide compounds |
| 08/19/2009 | CN101511789A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists |
| 08/19/2009 | CN101511787A Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use |
| 08/19/2009 | CN101511783A N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 08/19/2009 | CN101511780A Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as CPT-inhibitors |
| 08/19/2009 | CN101511775A Butyl and butynyl benzyl amine compounds |
| 08/19/2009 | CN101511431A Treating mycobacterial infections with Cyclipostins |
| 08/19/2009 | CN101511376A Cardiovascular preparation |
| 08/19/2009 | CN101511375A Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 08/19/2009 | CN101511374A Use of tylvalosin as antiviral agent |
| 08/19/2009 | CN101511373A Modified factor VIII and factor IX genes and vectors for gene therapy |
| 08/19/2009 | CN101511372A Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 08/19/2009 | CN101511371A Adhesive preparation |
| 08/19/2009 | CN101511370A Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 08/19/2009 | CN101511369A Methods and compositions for inhibiting angiogenesis. |
| 08/19/2009 | CN101511368A Methods and compositions for promoting activity of anti-cancer therapies. |
| 08/19/2009 | CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/19/2009 | CN101511366A Methods and compositions for increasing patient tolerability during myocardial imaging methods |
| 08/19/2009 | CN101511365A Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor |
| 08/19/2009 | CN101511364A Combination treatment for diabetes mellitus |
| 08/19/2009 | CN101511363A Antioxidant combinations for use in ruminant feed rations having a fat source |
| 08/19/2009 | CN101511362A Aqueous formulation comprising an antitumor agent |
| 08/19/2009 | CN101511361A Method of using substituted piperidines that increase p53 activity |
| 08/19/2009 | CN101511360A Compositions and method for the treatment of mucormycosis and other epiphyte diseases |
| 08/19/2009 | CN101511359A Benzotriazole kinase modulators |
| 08/19/2009 | CN101511358A Freeze-dried preparation of 1-methylcarbapenem |
| 08/19/2009 | CN101511357A Method for the treatment and prevention of ocular disorders |
| 08/19/2009 | CN101511356A O/W/O-type emulsion containing lignan compound, and composition comprising the same |
| 08/19/2009 | CN101511354A Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 08/19/2009 | CN101511353A Therapeutic delivery of carbon monoxide |
| 08/19/2009 | CN101511352A Lactam containing HCV inhibitors |
| 08/19/2009 | CN101511351A Combination methods of treating cancer |
| 08/19/2009 | CN101511350A Dioxo-alkanes and dioxo-alkenes |
| 08/19/2009 | CN101511349A Transdermal therapeutic system comprising norelgestromin forcontraception and hormone replacement |
| 08/19/2009 | CN101511348A Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 08/19/2009 | CN101511345A Immediate-release tablet formulations of a thrombin receptor antagonist |
| 08/19/2009 | CN101511344A Oral pharmaceutical composition of a poorly water-soluble active substance. |
| 08/19/2009 | CN101511343A Use of polyols to obtain stable polymorphous forms of rifaximin |
| 08/19/2009 | CN101511342A Dry powder compound formulations and uses thereof |
| 08/19/2009 | CN101511341A Sustained release formulations of aromatase inhibitors |
| 08/19/2009 | CN101511338A Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases |
| 08/19/2009 | CN101511188A Crystalline form of 5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin |
| 08/19/2009 | CN101511187A Piperidine and piperazine derivatives |
| 08/19/2009 | CN101511186A Dihydropyridine compounds and compositions for headaches |
| 08/19/2009 | CN101511185A Azole nucleosides and use as inhibitors of RNA and DNA varial polymerases |
| 08/19/2009 | CN101511184A Liquid pharmaceutical formulations for oral administration of a CGRP antagonist |
| 08/19/2009 | CN101511180A Preparation and utility of substituted carboxylic acid compounds |
| 08/19/2009 | CN101511179A Small molecule inhibitors of STAT3 and the uses thereof |
| 08/19/2009 | CN101508720A Triterpene extracts of achyranthes bidentata and uses in osteosporosis resistant medicament |
| 08/19/2009 | CN101508713A Glucoside containing 1,2,3-triazole structure, preparation method and application |
| 08/19/2009 | CN101508712A Glucoside containing tetrazole structure, preparation method and application |
| 08/19/2009 | CN101508696A 2-methyl-5-imidogen-benzo[d][1,3] oxazine[5-b] pyrazole compound, preparation method and application thereof |
| 08/19/2009 | CN101508695A Indolizine-peptide piperazine diketone derivatives, preparation and antimicrobial uses thereof |
| 08/19/2009 | CN101508693A Xylogen like flavonoid compounds, method of preparing the same and pharmaceutical use |
| 08/19/2009 | CN101508692A Anthranilamides, process for the production thereof, and pest controllers containing the same |
| 08/19/2009 | CN101508691A Sulphaminic acid benzothiophene ester derivative used as steroid sulfatase restrainer |
| 08/19/2009 | CN101508674A Benazepine-2-ketone compound containing ethylene imine ring, preparation and application thereof |
| 08/19/2009 | CN101508671A Aza saccharide compounds, synthesis and uses thereof |
| 08/19/2009 | CN101508668A Novel C8 side-chain hydrogenated iso-indole ketone compounds, preparation method and application thereof |
| 08/19/2009 | CN101508652A Hyperpiesis resistant compound and method of preparing the same |
| 08/19/2009 | CN101507821A Medicine for treating malignant cerebroma and breast cancer by combining gene and chemotherapy medicine and preparation method thereof |
| 08/19/2009 | CN101507820A Manufacture of polyglutamate-therapeutic agent conjugates |
| 08/19/2009 | CN101507819A Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 08/19/2009 | CN101507818A Capsaicin beta-cyclodectrin inclusion-compound and liposome and gel of inclusion-compound |
| 08/19/2009 | CN101507804A Medicine for injury pain and its preparation technique |
| 08/19/2009 | CN101507787A Dietetic medicine preparation capable of promoting lactation and preparation method thereof |
| 08/19/2009 | CN101507772A Traditional Chinese medicine paste for treating mouth facial phlegmona and preparation method thereof |
| 08/19/2009 | CN101507768A Qiwei dan capable of treating arthralgia due to wind cold dampness |
| 08/19/2009 | CN101507766A Preparation method of traditional Chinese medicine capsules with blood-fat reduction and health-care function and use thereof |
| 08/19/2009 | CN101507760A Medicine composite for treating kidney disease |
| 08/19/2009 | CN101507750A Use of kuhseng total-flavone in preparing medicine |
| 08/19/2009 | CN101507748A External medicine liquor for treating common cold and preparation method thereof |
| 08/19/2009 | CN101507745A Buccal tablet capable of relieving itching, cough and asthma and manufacture method thereof |
| 08/19/2009 | CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof |
| 08/19/2009 | CN101507733A Nano micromolecule hyaluronic acid and preparation method thereof |
| 08/19/2009 | CN101507732A Preparation capable of preventing and treating oviduct accretion |
| 08/19/2009 | CN101507731A Chitosan uterus-neck antibiotic film and preparation method thereof |
| 08/19/2009 | CN101507730A Combination of epigallocatechin-3-gallate and cerubidin and use thereof |
| 08/19/2009 | CN101507729A Use of ginsenoside Compound K in preparing medicine capable of preventing and treating atherosclerosis |
| 08/19/2009 | CN101507728A Composite for preventing and treating body acidification of diabetic |